Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission
Authors:
- Enes Ali KurtEKEnes Ali Kurt
- Oğuz Kağan BakkaloğluOBOğuz Kağan Bakkaloğlu
- Tuğçe EşkazanTETuğçe Eşkazan
- Selma AkdoğanSASelma Akdoğan
- Uğur ÖnalUÖUğur Önal
- Selçuk CandanSCSelçuk Candan
- Rıdvan KaraaliRKRıdvan Karaali
- Bilgül MeteBMBilgül Mete
- Yalım DikmenYDYalım Dikmen
- Murat TuncerMTMurat Tuncer
- İbRahim HatemiIHİbRahim Hatemi
- Kadir BalKBKadir Bal
Open Access
- 15 February 2023
- journal article
- research article
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 34 (4) , 322-331
Abstract
Background: This study aimed to find the prevalence of gastrointestinal symptoms in hospitalized COVID-19 patients and to investigate the effects of gastrointestinal symptoms on the course of the disease during hospitalization. Methods: Patients who were hospitalized due to COVID-19 were included in this retrospective study. The diagnostic method of COVID-19 was either a positive reverse transcription polymerase chain reaction test or a typical finding in chest computed tomography. This study was conducted by contacting patients by phone 1 month after they were discharged from hospital to investigate gastrointestinal symptoms. Patients’ laboratory findings at the time of admission, medications they used, and clinical findings were obtained from hospital records retrospectively. Patients with gastrointestinal symptoms were divided into 2 groups according to the start of treatment: pre-treatment and post-treatment groups. Results: At least 1 gastrointestinal symptom (anorexia, weight loss, diarrhea, nausea, vomiting, and abdominal pain) was present in 67.5% of 435 patients (55.6% male, mean age 52.8). If anorexia and weight loss are excluded, the rate of the presence of at least 1 gastrointestinal symptom is 54%. Gastrointestinal symptoms were present in 48.9% before the initiation of COVID-19 treatment. The most prevalent 3 symptoms were anorexia, weight loss, and diarrhea (56%, 52%, and 35.6%, respectively). Presence of pre-treatment gastrointestinal symptoms was associated with elevated C-reactive protein levels. Pre-treatment gastrointestinal symptoms were more common in those who received oxygen supply and who were intubated. Resolution of gastrointestinal symptoms takes longer time in those who were admitted to intensive care unit. Weight loss and diarrhea were more common in COVID-19 patients with gastrointestinal symptoms who were intubated than who were not intubated. Abdominal pain was not found to be a significant predictor of disease severity. Conclusion: The prevalence of at least 1 gastrointestinal symptom in hospitalized COVID-19 patients was 67%. The most prevalent symptoms were anorexia, weight loss, and diarrhea. Presence of pre-treatment gastrointestinal symptoms was associated with elevated C-reactive protein levels, use of oxygen supply, and intubation. Gastrointestinal symptoms persist longer in those admitted to intensive care unit. Cite this article as: Kurt EA, Bakkaloğlu OK, Eşkazan T, et al. Comparison of hospitalized COVID-19 patients in terms of disease course according to the presence of gastrointestinal symptoms before and after admission. Turk J Gastroenterol. 2023;34(4):322-331.Keywords
This publication has 10 references indexed in Scilit:
- Disease Course and Outcomes of COVID-19 Among Hospitalized Patients With Gastrointestinal ManifestationsClinical Gastroenterology and Hepatology, 2021
- Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsGastroenterology, 2021
- Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective StudyFrontiers in Medicine, 2020
- Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort StudyGastroenterology, 2020
- SARS-CoV-2 productively infects human gut enterocytesScience, 2020
- Clinical characteristics and outcomes of COVID‐19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, ChinaJournal of Medical Virology, 2020
- Evidence for Gastrointestinal Infection of SARS-CoV-2Gastroenterology, 2020
- Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to knowAmerican Journal of Obstetrics and Gynecology, 2020
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptomsGut, 2020
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004